| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/02/2008 | CN100398137C Compound traditional Chinese medicine for treating fibroid and muller-iosis and its preparation method |
| 07/02/2008 | CN100398135C Effervescent tablet for treating elytritis and its preparation method |
| 07/02/2008 | CN100398129C Chinese-medicinal preparation for treating femur head aseptic necrosis |
| 07/02/2008 | CN100398127C Wind dispelling spray and its preparation process |
| 07/02/2008 | CN100398123C Medicine for treating diabetes of blood stasis complicated kidney spleen deficiency type |
| 07/02/2008 | CN100398116C Medicine for treating stomatocase and laryngopharyngitis |
| 07/02/2008 | CN100398114C Composition of stachyose and bee product |
| 07/02/2008 | CN100398112C Medicine for treating hyperphosphatemia and its preparing method |
| 07/02/2008 | CN100398111C Powder placed inside shoes for treating foot odor and beriberi |
| 07/02/2008 | CN100398110C Preparation containing ultra-low-doses of estrogen, patch and reagent box |
| 07/02/2008 | CN100398109C Steroid derived antibiotics |
| 07/02/2008 | CN100398108C Nasal cavity nebula containing scopolamine hydrobromide |
| 07/02/2008 | CN100398107C Use of IkappaB-kinase inhibitors in preparing medicament for pain therapy |
| 07/02/2008 | CN100398106C Use of nk-1 receptor antagonists against benign prostatic hyperplasia |
| 07/02/2008 | CN100398105C 1,3-substitued cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as pharmaceuticals |
| 07/02/2008 | CN100398104C Medicament comprising combination of antithrombotic agent with pyrazolone derivative |
| 07/02/2008 | CN100398103C Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 07/02/2008 | CN100398102C Medicament for kidney failure containing oxaluric acid derivative |
| 07/02/2008 | CN100398101C Use of pbromophenacylbromide in preparing medicament for preventing and/or treating asthma |
| 07/02/2008 | CN100398100C Method for extracting high-content solanesol extract by liquid-liquid two-phase method |
| 07/02/2008 | CN100398096C Spherical particles of taurine, and preparation method |
| 07/02/2008 | CN100398094C Formoterol superfine formulation |
| 07/02/2008 | CN100398093C Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 07/02/2008 | CA2640046A1 2-substituted benzimidazoles as selective androgen receptor modulators (sarms) |
| 07/01/2008 | USRE40418 Treatment of neoplasms with CCI-779/EKB-569 combination |
| 07/01/2008 | US7395112 Method and apparatus for treating tumors using low strength electric fields |
| 07/01/2008 | US7395111 Transdermal delivery system for water insoluble drugs |
| 07/01/2008 | US7393977 Dicarboxylic acid salt of sibutramine |
| 07/01/2008 | US7393974 Process for the preparation of 1-(aminomethyl) cyclohexaneacetic acid |
| 07/01/2008 | US7393960 peroxisome proliferator activated receptor agonist such as (2R)-2-(3-{[3-(4-chlorophenoxy)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]methyl}phenoxy)butanoic acid, used for treatment and control of metabilic disorders |
| 07/01/2008 | US7393959 Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 07/01/2008 | US7393958 Triamide-substituted heterobicyclic compounds |
| 07/01/2008 | US7393957 Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| 07/01/2008 | US7393953 Polymeric acyl derivatives of indoles |
| 07/01/2008 | US7393951 antisense to a nucleotide sequence of positions 47 to 51 of 7SL RNA of the signal recognition particle (SRP); inhibitor of cancer cell growth |
| 07/01/2008 | US7393950 To inhibit the growth of tumor cells in mammals |
| 07/01/2008 | US7393944 Lymphocytes; transcription factors; interferons |
| 07/01/2008 | US7393938 Use of lipid conjugates in the treatment of diseases |
| 07/01/2008 | US7393937 N-acetylglucosamine derivatives and use thereof |
| 07/01/2008 | US7393933 Hepatitis B monoclonal antibodies |
| 07/01/2008 | US7393911 antireflection and antiblocking characteristics to synthetic polymer films and sheets when applied to their surface or caused to be contained, respectively, and adherence and slip characteristics to a skin care cosmetic material when caused to be contained |
| 07/01/2008 | US7393875 Reducing islet amyloid polypeptide (IAPP) associated deposit; type II diabetes |
| 07/01/2008 | US7393874 Reacting tolterodine with tartaric acid in solvent; spray drying |
| 07/01/2008 | US7393873 Arylsulfonamide derivatives |
| 07/01/2008 | US7393872 Sodium channel blocker compositions and the use thereof |
| 07/01/2008 | US7393871 antitumor and antiproliferative agents; inert in acqueous solution at both pH 5.5. and 7.4 |
| 07/01/2008 | US7393870 3-(heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 07/01/2008 | US7393869 3-[5-(4-methylbenzylidene)-4-oxo-2-thioxothiazolidin-3-yl]-N-(4-sulfamoylphenyl)-propionamide; compounds are protein tyrosine phosphatse inhibitors; antiinflmmatory, anticarcinogenic agents |
| 07/01/2008 | US7393868 AMPA receptor potentiators |
| 07/01/2008 | US7393867 6-phenylsulfanyl-4H-pyrrolo[2,3-d]thiazole-5-carboxylic acid amide; mood disorders; sleep disorders; major depressive disorder; circadian rhythm sleep disorders; jet lag syndrome; bipolar disorders; reaction with diaryldisulfide or diheteroaryldisulfides to give desired compounds |
| 07/01/2008 | US7393866 Anticholesterol agents; antilipemic agents; cardiovascular disorders; antiischemic agents; anticancer agents |
| 07/01/2008 | US7393865 Sleep inducing compounds and methods relating thereto |
| 07/01/2008 | US7393864 Use of ClC3 chloride channel blockers to modulate vascular tone |
| 07/01/2008 | US7393863 Methods of using N-{[2-(2,6-dioxo(3-piperidyl)-1,3-dioxoisoindolin-4-yl]methyl}cyclopropyl-carboxamide for the treatment and management of myelodysplastic syndromes |
| 07/01/2008 | US7393862 Immunomodulators; chemotherapy, radiation therapy, hormonal therapy, biological therapy, immunotherapy |
| 07/01/2008 | US7393861 Derivatives of 4-aminopiperidine and their use as a medicament |
| 07/01/2008 | US7393860 for the treatment of peptic ulcer disorders; (7R,8R,9R)-2,3-Dimethyl-8-hydroxy-7-(2-methoxyethoxy)-9-phenyl-7,8,9,10-tetrahydro-imidazo-[1,2-h][1,7] naphthyridine or a pharmaceutically acceptable salt |
| 07/01/2008 | US7393859 Amide substituted imidazoquinolines |
| 07/01/2008 | US7393858 Tetrahydropyran compounds as tachykinin antagonists |
| 07/01/2008 | US7393857 Use of 5-HT3 receptor antagonists for treating musculoskeletal diseases |
| 07/01/2008 | US7393856 Anti-viral uses of borinic acid complexes |
| 07/01/2008 | US7393855 Treating human herpes virus, human immunodeficiency virus, and hepatitis B virus; optionally administered with other antiviral agents; (E)-9-{[2,2-bis-(hydroxymethyl)cyclopropylidene]methyl}adenine |
| 07/01/2008 | US7393854 Respiratory system disorders; asthma |
| 07/01/2008 | US7393853 9-(2-Oxo-2-phenyl-ethyl)-2-(4-pyridinyl)-8-(trifluoromethyl)-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; glycogen synthase kinase 3 beta and tau protein kinase inhibitor; neurodegenerative diseases: Alzheimer's disease, vascular dementia; acute stroke, retinopathy, glaucoma, alopecia |
| 07/01/2008 | US7393852 analgesics; antiinflammatory agents; antiarthritic agents;Alzheimer's disease; cirrhosis; antiallergens; antihistamines ; anticancer agents; vision defects |
| 07/01/2008 | US7393851 Azaindole derivatives as inhibitors of p38 kinase |
| 07/01/2008 | US7393850 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 07/01/2008 | US7393849 N-[4-Amidinobenzoyl]-N-[3-phenoxybenzyl]-3-(4-biphenyl)-alanyl-glycyl-amide; anticarcinogenic, antidiabetic, anticholesterol agent, cardiovascular disorders, osteoporosis |
| 07/01/2008 | US7393848 Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds |
| 07/01/2008 | US7393847 Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions |
| 07/01/2008 | US7393846 phosphodiesterase type 4 inhibitors; N-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide; antiinflammatory agent, antiallergen; asthma or chronic obstructive pulmonary disease |
| 07/01/2008 | US7393845 2-{2-[4-(2,3-Dihydrobenzo[1,4]dioxin-5-yl)piperazin-1-yl]ethylsulfanyl}-6-methylnicotinonitrile; serotonin and dopamine receptor antagonist, serotonin reuptake inhibitor; anxiolytic agent, antidepressant; panic and obsessive compulsive disorder, social phobia, eating disorders, psychosis |
| 07/01/2008 | US7393844 Tetrahydropyranyl cyclopentyl heterocyclic amide modulators of chemokine receptor activity |
| 07/01/2008 | US7393843 amyloid precursor protein and gamma -secretase inhibitor; 3,4,6,7,8,9-Hexahydro-2-methyl-3-oxo-2H-naphtho[2,3-e]-1,2-thiazine-4-carboxanilide 1,1-dioxide; neurodegenerative disease: Alzheimer's disease, amyloid plaque, Parkinson's disease, Down's syndrome, hemorrhage, arteriosclerosis |
| 07/01/2008 | US7393842 Pyrazole analogs acting on cannabinoid receptors |
| 07/01/2008 | US7393841 for improved microcirculation, cryo-conservation of blood components such as erythrocytes of granulocytes, and as sedimentation aid in cell separation in connection with leucapheresis |
| 07/01/2008 | US7393840 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 07/01/2008 | US7393839 Crystalline forms A and B of Levovirin valinate hydrochloride (2-(S)-amino-3-methyl-butyric acid 5S-(3-carbamoyl-[1,2,4]triazol-1-yl)-3R,4S-dihydroxy-tetrahydrofuran-2S-yl methyl ester, monohydrochloride): hemihydrate; Hepatitis C virus; physical and chemical stability; solubility and flowability |
| 07/01/2008 | US7393838 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 07/01/2008 | US7393837 Method for treating metabolic bone disease such as osteomalacia and osteoporosis in a patient by administering a compound that modulates phosphate regulating endopeptidase homolog (PEX) expression and/or PEX enzymatic activity |
| 07/01/2008 | US7393836 have an inhibiting effect on the sodium-dependent glucose cotransporter SGLT; treatment of metabolic disorders |
| 07/01/2008 | US7393834 LHRH-antagonists in the treatment of fertility disorders |
| 07/01/2008 | US7393830 Prolactin induced increase in neural stem cell numbers |
| 07/01/2008 | US7393825 Restoring balance in vascular tone without systemic effect in normal vasculature; administration of minimal amounts of nitric oxide donors and/or guanyl cyclase activators |
| 07/01/2008 | US7393824 Methods of peptide preparation |
| 07/01/2008 | US7393655 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder |
| 07/01/2008 | US7393552 Compositions comprising protein and fatty acid |
| 07/01/2008 | US7393545 Lipstatin derivative—soluble fiber tablets |
| 07/01/2008 | US7393543 Vaginally administratable progesterone-containing tablets and method for preparing same |
| 07/01/2008 | US7393526 Systemic gene delivery vehicles for the treatment of tumors |
| 07/01/2008 | US7393524 Baculovirus vectors comprising a capsid polypeptide fused to a GNRH polypeptide |
| 07/01/2008 | US7393522 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 07/01/2008 | US7393478 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 06/29/2008 | CA2601963A1 Method of enriching glucoraphanin in radish seed preparations |
| 06/26/2008 | WO2008077130A2 Homogeneous paste and gel formulations |
| 06/26/2008 | WO2008077127A2 Use of modafinil to treat restless leg syndrome |
| 06/26/2008 | WO2008077106A1 L-histidine in ophthalmic solutions |
| 06/26/2008 | WO2008077103A1 Preperation and utility of ccr5 inhibitors |
| 06/26/2008 | WO2008077092A2 Combined effects of topiramate and ondansetron on alcohol consumption |
| 06/26/2008 | WO2008077089A1 Pyrrolidinanilines |